BHI News Section Archives - Page 42 of 1201

News

June 12, 2024

REGENXBIO Announces Leadership Transition

ROCKVILLE, Md., June 12, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that Curran Simpson, Chief Operating Officer, has been appointed as President, Chief…

Andy

Love0

News

June 11, 2024

TEDCO Invests in Kubanda Cryotherapy

Biotechnology company innovates treatment for pets with lumps, bumps and cancer COLUMBIA, Md., (June 11, 2024) — TEDCO, Maryland’s economic…

Andy

Love0

News

June 10, 2024

Linshom Medical Picked by TechConnect as Finalist in the Medical Threat Challenge

BALTIMORE, MD, US, June 10, 2024 /EINPresswire.com/ -- Linshom Medical, a start-up medical device company was selected to present at the…

Andy

Love0

News

June 10, 2024

IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol

-- Study Deepens Understanding of Treatments for Alzheimer’s Patients, Enabling More Effective Treatments -- POTOMAC, Md.--(June 10, 2024)--IGC Pharma, Inc. (NYSE…

Andy

Love0

News

June 10, 2024

HyperSpectral Announces $8.5M Series A Funding to Accelerate Deployment of Spectral Artificial Intelligence Software

Company Focused on Bringing Industry-Leading Technology to Market in Food Safety and MedTech Industries ALEXANDRIA, Va., June 5, 2024 /PRNewswire/ -- HyperSpectral, the…

Andy

Love0

News

June 8, 2024

US FDA approves expanded age indication for GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk

PHILADELPHIA, June 07, 2024--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved…

Andy

Love0

News

June 6, 2024

Barinthus Bio’s VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B

OXFORD, United Kingdom, June 06, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), a biopharmaceutical company developing novel T…

Andy

Love0

News

June 6, 2024

REPROCELL USA Receives Funding from Maryland Stem Cell Research Fund (MSCRF)

REPROCELL USA is proud to announce that it has received funding from MSCRF for both proposals it has submitted for the MSCRF's January…

Andy

Love0

News

June 5, 2024

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers

ROCKVILLE, Md., June 5, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential…

Andy

Love0

News

June 4, 2024

JPMorgan Chase Furthers Commitment in Baltimore with Multimillion-Dollar Philanthropic Capital

The firm deepens its 130-year presence in Baltimore and commitment to driving inclusive economic growth; advances $20 million five-year philanthropic…

Andy

Love0

BHI News Section

REGENXBIO Announces Leadership Transition

TEDCO Invests in Kubanda Cryotherapy

Linshom Medical Picked by TechConnect as Finalist in the Medical Threat Challenge

IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol

HyperSpectral Announces $8.5M Series A Funding to Accelerate Deployment of Spectral Artificial Intelligence Software

US FDA approves expanded age indication for GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk

Barinthus Bio’s VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B

REPROCELL USA Receives Funding from Maryland Stem Cell Research Fund (MSCRF)

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers

JPMorgan Chase Furthers Commitment in Baltimore with Multimillion-Dollar Philanthropic Capital

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search